Chinese medicine industry how Nirvana rebirth-.docVIP

 PAGE \* MERGEFORMAT 7 Chinese medicine industry how Nirvana rebirth? Chinese medicine industry, nearly to be a mess, and in the policy and the market among the double attack in the Chinese medicine industry chain, cultivation, development, manufacturing, business promotion, basically in all aspects of dispersion, the concentration is well below the industry pharmaceutical industry average. Five years ago That is the pseudo-science of medicine is almost the debate aside from the roots of TCM. Fortunately, the relevant departments to come forward even behind after the debate ended only this point, the health insurance to help, and also preserve traditional Chinese medicine to help the. Today, however, remains a cause of environment for the development of Chinese medicine, because medicine is subject to market and policy of the attack. Market environment Chinese companies in the pharmaceutical industry supply chain may be the most vulnerable, mainly reflected in its raw materials (medicines supply uncertainty. First, the uncertainty of supply, due to Chinese herbal medicine planting long cycle of climate, environment and other factors, impact, and its output in a ‘relying’ state. For example, Panax ginseng are ‘ three years a familiar. ‘ Second, the price is very unstable. In recent years, due to extreme weather, hot money speculation, inflation and other factors, prices of primary products of Chinese herbal medicines showed the trend of soaring, according to China Association of Chinese herbal medicine Information Center released the monitoring report shows that compared to last year, focus on monitoring in 537 varieties of herbs, the prices of medicines in May a total of 371 species, representing about 69%, while in 2010 it has 537 kinds of Chinese herbal medicines in the 84% price increase, the average increase was 109%, rose more than 100% up to 96 varieties, among which the most typical and heterophylla than thirty-seven according to the market i